Based on this differentially methylated region (DMR), we designed methylation-specific HOXA2 primers to quantify the methylation percentages of the same NPC clinical samples by quantitative methylation specific PCR (Q-MSP-PCR) analysis. This evidence concerns the gene HOXA2 and nasopharyngeal carcinoma.